Congratulations to Dr. Guillermo Delgado-Garcia, OMI fellow from Mexico, on receiving the Bruce S. Schoenberg International Award in Neuroepidemiology, sponsored by the American Academy of Neurology and endowed by GlaxoSmithKline, Inc.!
Why the recipient was chosen?
It is a great pleasure to present the Bruce Schoenberg Award in Neuroepidemiology to Dr. Delgado-Garcia. Dr. Delgado did his medical training in Mexico, including his internal medical residency, clinical neurology residency and Masters in Science. He also subsequently received his Masters in Neuroscience in France and is now in a combined clinical-research fellowship in Alberta, Canada. Dr. Delgado-Garcia has published over forty peer-reviewed articles, including topics on the epidemiology of neuromyelitis optica (NMO) spectrum disorder, Guillain Barre Syndrome (GBS) in Mexican adults, and more recently around neurological conditions in the context of COVID-19. He presented an abstract on olfactory dysfunction through a national survey project he led for Mexican health care workers. Given his significant work in neuroepidemiology, and future prospects as a leader in neuroepidemiology in Mexico, Dr. Delgado-Garcia is very well deserving of this award.
Dr. Delgado-Garcia attended the OMI Neurology Seminar in 2018 where the course directors, Drs. Dara Jamieson and Eugen Trinka, noticed his excellent participation and achievement of the best test result.
I sincerely believe that the diversity of the topics addressed in this seminar will surely enrich my training as a neurology resident and, therefore, my clinical performance in daily activities. I want to thank Alianza Médica para la Salud, the American Austrian Foundation, the faculty, and my fellow attendees for this great opportunity. I really hope that all of us continue to be in contact and working together to achieve greater goals for the benefit of our nations.
Dr. Guillermo Delgado-Garcia